SCHEMBL20858960

SCHEMBL20858960

COc1cccc(/C=C/C(=O)c2c(OC)cc(C)c(C3=CCN(C)CC3)c2O)c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
ALOX5 P09917 1/20 0.45
NFE2L2 Q16236 2/20 0.43
MAOB P27338 2/20 0.43
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
NTSR1 P30989 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
RELA Q04206 1/20 0.41
CHRNA7 P36544 1/20 0.41
ABCB1 P08183 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL746358 0.93 NPC1 (0.46) RAB9ANPC1ALOX5NFE2L2MAOB
SCHEMBL7027348 0.90 NPC1 (0.44) RAB9ANPC1ALOX5NFE2L2MAOB
SCHEMBL20858973 0.88 MAOB (0.40) RAB9ANFE2L2MAOBCYP1A2MAPT
SCHEMBL20858963 0.88 ABCG2 (0.51) NFE2L2MAOBMAPTALDH1A1MEN1
SCHEMBL20858985 0.85 CA1 (0.47) MAPTSMN1; SMN2TP53ALDH1A1LMNA
SCHEMBL20858956 0.85 MAPT (0.54) MAOBCYP1A1CYP1A2MAPTTP53
SCHEMBL745720 0.85 ABCB1 (0.53) RAB9ANPC1ALOX5CYP1A1CYP1A2
SCHEMBL20858990 0.84 MAPT (0.45) MAOBMAPTTDP1RELAABCB1
SCHEMBL20858978 0.84 NFKB1 (0.48) ALOX5MAOBMAPTTDP1RELA
SCHEMBL20858996 0.83 ABCB1 (0.51) MAOBMAPTABCB1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2429292-B1 COMPOUNDS AND COMPOSITIONS COMPRISING CDK INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER GEORGIA STATE UNIV RESEARCH FOUNDATION (US) 2019-04-03 EP disclosed